Aurinia Pharmaceuticals Inc Earnings

The next earnings date for Aurinia Pharmaceuticals Inc is October 30, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Aurinia Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
10/30/2025	$0.15

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Aurinia Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/31/2025	---	$0.16	14.29%
04/30/2025	Before Market	$0.16	60.00%
02/13/2025	Before Market	$0.01	162.50%
11/07/2024	Before Market	$0.10	900.00%
08/01/2024	Before Market	$0.01	0.00%
05/02/2024	Before Market	$-0.03	78.57%
02/15/2024	Before Market	$-0.19	-18.75%
11/02/2023	Before Market	$-0.09	47.06%
08/03/2023	Before Market	$-0.08	55.56%
05/04/2023	Before Market	$-0.18	18.18%
02/28/2023	Before Market	$-0.18	33.33%
11/03/2022	Before Market	$-0.06	64.71%
08/04/2022	Before Market	$-0.25	-13.64%
05/10/2022	Before Market	$-0.27	0.00%
02/28/2022	Before Market	$-0.25	7.41%
11/03/2021	Before Market	$-0.39	-18.18%
08/05/2021	After Market	$-0.37	-2.78%
05/06/2021	After Market	$-0.40	-11.11%
02/24/2021	Before Market	$-0.05	79.17%
11/10/2020	After Market	$-0.28	-21.74%
08/11/2020	After Market	$-0.26	-13.04%
05/14/2020	After Market	$-0.15	44.44%
03/05/2020	After Market	$-0.78	-271.43%
11/14/2019	After Market	$-0.21	-5.00%
08/06/2019	After Market	$-0.17	0.00%
05/14/2019	After Market	$-0.14	6.67%
03/19/2019	After Market	$-0.17	5.56%
11/08/2018	After Market	$-0.21	-10.53%
08/09/2018	After Market	$-0.19	-26.67%
05/10/2018	After Market	$-0.18	-5.88%
03/15/2018	After Market	$-0.04	71.43%
11/14/2017	After Market	$-0.16	-6.67%
08/10/2017	After Market	$-0.03	75.00%
05/15/2017	Before Market	$-0.92	-666.67%
03/09/2017	Before Market	$-0.22	-83.33%
11/04/2016	After Market	$-0.21	-50.00%
08/05/2016	Before Market	$-0.10	9.09%
05/11/2016	After Market	$-0.13	7.14%
03/18/2016	After Market	$-0.13	13.33%
11/13/2015	After Market	$-0.16	27.27%
08/11/2015	After Market	$-0.02	90.00%
05/15/2015	After Market	$-0.27	-92.86%
03/30/2015	After Market	$-0.15	-25.00%
11/12/2014	After Market	$-0.08	---
08/15/2014	---	$-0.13	---
05/16/2014	---	$-0.24	---
03/28/2014	---	$0.11	---
11/22/2013	---	$-0.45	---
08/14/2013	---	$-0.25	---
05/16/2013	---	$-0.20	---
11/14/2012	---	$-0.49	---
03/27/2009	---	$-2.50	-25.00%
11/14/2008	---	$-2	20.00%
08/06/2008	---	$-2.50	0.00%
05/06/2008	---	$-2.50	37.50%
03/18/2008	---	$-4	11.11%
11/06/2007	---	$-3.50	27.54%
08/14/2007	---	$-4.50	0.00%
05/09/2007	---	$-4	15.79%
03/16/2007	---	$-4.50	6.83%
11/14/2006	---	$-4	11.11%
08/03/2006	---	$-4	0.00%
05/15/2006	---	$-3	53.85%
03/14/2006	---	$-5.50	-20.35%
11/04/2005	---	$-4	-33.33%
08/09/2005	---	$-5.50	15.38%
05/13/2005	---	$-5.50	21.43%
03/02/2005	---	$-6.50	0.00%
11/10/2004	---	$-6	0.00%
08/10/2004	---	$-3	7.69%
05/13/2004	---	$-2.50	37.50%
03/29/2004	---	$-5.50	-57.14%
11/25/2003	---	$-4	-6.67%
08/25/2003	---	$1	-66.67%
05/23/2003	---	$-4.50	-50.00%
03/11/2003	---	$-3.50	-75.00%
11/26/2002	---	$3	---

More About Aurinia Pharmaceuticals Inc

Website

https://www.auriniapharma.com

Country

USA

Full Time Employees

130

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

“Aurinia Pharmaceuticals Inc Earnings” Can Refer to the Aurinia Pharmaceuticals Inc Earnings Date

Some people say “Aurinia Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Aurinia Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Aurinia Pharmaceuticals Inc Stock on the Earnings Date

If you own Aurinia Pharmaceuticals Inc stock (AUPH) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Aurinia Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Aurinia Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Aurinia Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Aurinia Pharmaceuticals Inc earnings or anything else related to the stock market.